China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,766 | 203,204 | 204,034 | 180,117 | 144,938 |
| Marketable Securities | N/A | N/A | N/A | N/A | 38,033 |
| Receivables | 33,919 | 40,189 | 38,259 | 30,593 | 25,145 |
| Inventories | 156,413 | 146,936 | 136,038 | 130,877 | 126,395 |
| Other current assets | 0 | 7,028 | 4,901 | 10,308 | 10,056 |
| TOTAL | $389,418 | $434,873 | $404,819 | $373,558 | $369,113 |
| Non-Current Assets | |||||
| PPE Net | 132,092 | 134,425 | 126,418 | 115,501 | 105,364 |
| Investments And Advances | 10,615 | 9,615 | 8,580 | 8,543 | 8,718 |
| Intangibles | 23,389 | 24,197 | 24,228 | 24,932 | 23,576 |
| Other Non-Current Assets | 49,444 | 47,135 | 47,686 | 49,630 | 44,695 |
| TOTAL | $215,540 | $215,372 | $206,912 | $198,607 | $182,354 |
| Total Assets | $604,958 | $650,246 | $611,731 | $572,165 | $551,467 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 65,957 | 61,908 | 55,802 | 48,621 | 67,144 |
| TOTAL | $73,441 | $72,398 | $64,492 | $56,848 | $71,655 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,882 | -138 | 799 | 168 | 4,274 |
| TOTAL | $10,380 | $10,886 | $11,718 | $11,123 | $12,849 |
| Total Liabilities | $83,821 | $83,283 | $76,211 | $67,971 | $84,505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,185 | 27,138 | 26,893 | 26,591 | 26,591 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 438,483 | 419,046 | 390,654 | 359,901 | 333,704 |
| Other shareholders' equity | 33,191 | 78,791 | 83,598 | 90,640 | 84,175 |
| TOTAL | $521,137 | $566,963 | $535,520 | $504,193 | $466,962 |
| Total Liabilities And Equity | $604,958 | $650,246 | $611,731 | $572,165 | $551,467 |